Skip to Main Content

Paper Details

Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential.
bioRxiv
0
2023
Bat-CoV, COVID-19, COVID-19 disease, GS-441524, GS-5245, HCoV-NL63, MERS, MERS-, MERS-CoV, Middle East Respiratory Syndrome coronavirus, ODV, Obeldesivir, RNA-dependent viral RNA polymerase, RdRp, SARS, SARS-, SARS-CoV, SARS-CoV-2, acute lung, coronaviruses, humans, mice, monoclonal, mouse, nirmatrelvir, nucleoside, protease (M, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Boyd L YountUniversity of North Carolina at Chapel Hill
Stephanie A MontgomeryUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
  • 1 - 8

Datasets

Release 1.2